|
Real-time Estimate
Cboe BZX
21:20:53 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 55.54 USD | -0.87% |
|
-4.51% | -29.83% |
| 06:05pm | Ionis Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 08:45 AM | |
| 09-09 | BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93 | MT |
| Market Cap | 9.31B 8.01B 7.55B 6.88B 12.86B 890B 12.98B 89.97B 34.63B 451B 34.96B 34.2B 1,434B | P/E 2026 * |
-15.4x | P/E 2027 * | -29.8x |
|---|---|---|---|---|---|
| Enterprise Value | 9.21B 7.92B 7.47B 6.81B 12.72B 880B 12.84B 88.97B 34.24B 446B 34.57B 33.82B 1,418B | EV / Sales 2026 * |
10.1x | EV / Sales 2027 * | 6.78x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
Tradegate
| ISI | Real-time | |
|
London S.E.
| 0JDI | Delayed | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Borsa Italiana
| 1IONS | End-of-day quote | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Boerse Muenchen
| ISI | Real-time | |
|
Xetra
| ISI | Delayed |
Last Transcript : Ionis Pharmaceuticals, Inc.
| 1 day | -0.87% | ||
| 1 week | -4.51% | ||
| Current month | -8.04% | ||
| 1 month | -2.51% | ||
| 3 months | -24.29% | ||
| 6 months | -26.63% | ||
| Current year | -29.83% |
| 1 week | 52.15 |  | 58.96 |
| 1 month | 52.15 | | 64.19 |
| Current year | 50 | | 86.74 |
| 1 year | 50 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 01/07/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 01/05/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 13/12/2005 |
| Director/Board Member | 73 | 01/05/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 25/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Others | Chief Technology Officer | 110 | 0.0001% | ||
| 31/08/26 | Others | Executive/Senior Manager | 58 | 0.0000% | ||
| 31/08/26 | Others | Founder | 98 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.87% | -4.51% | -13.27% | +34.44% | 9.31B | |
| -0.56% | -8.08% | -3.88% | +9.81% | 46.38B | |
| -1.49% | -2.97% | +405.81% | +522.45% | 44.51B | |
| +0.38% | -4.92% | +40.46% | +19.94% | 42.3B | |
| -2.50% | -5.55% | +9.11% | +63.71% | 39.91B | |
| -1.26% | -2.95% | +12.00% | +40.55% | 32.79B | |
| -0.09% | -3.85% | - | - | 17.13B | |
| -0.05% | -1.20% | +22.98% | +109.86% | 16.36B | |
| -0.03% | -3.46% | +12.68% | +30.90% | 14.31B | |
| -1.84% | -6.78% | +78.41% | +36.96% | 13.29B | |
| Average | -0.84% | -3.64% | +62.70% | +96.51% | 27.63B | |
| Weighted average by Cap. | -0.92% | -3.43% | +84.23% | +121.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 913M 785M 741M 675M 1.26B 87.26B 1.27B 8.82B 3.39B 44.26B 3.43B 3.35B 141B | 1.38B 1.19B 1.12B 1.02B 1.91B 132B 1.93B 13.36B 5.14B 67.03B 5.19B 5.08B 213B |
| Net income | -584M -502M -474M -431M -807M -55.81B -814M -5.64B -2.17B -28.31B -2.19B -2.14B -89.91B | -314M -270M -255M -232M -434M -30.06B -438M -3.04B -1.17B -15.25B -1.18B -1.15B -48.42B |
| Net Debt | -103M -88.57M -83.57M -76.13M -142M -9.85B -144M -995M -383M -4.99B -387M -378M -15.86B | 68.31M 58.74M 55.43M 50.49M 94.39M 6.53B 95.25M 660M 254M 3.31B 257M 251M 10.52B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $55.52 | -0.89% | 1,199,475 |
| 09/09/26 | $56.02 | -1.22% | 3,037,757 |
| 08/09/26 | $56.71 | -2.38% | 9,175,745 |
| 04/09/26 | $58.09 | -0.07% | 2,671,092 |
| 03/09/26 | $58.13 | -5.22% | 4,347,907 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
